For adults with advanced melanoma that has spread or cannot be removed by surgery

Clinical Trial Results

OPDIVO®—Proven in 3 Clinical Trials for Advanced Melanoma

STUDY 1: PROVEN RESULTS AGAINST ANOTHER IMMUNOTHERAPY

In one trial, OPDIVO alone was shown to reduce the risk of the cancer spreading, growing or getting
worse by 43% compared to ipilimumab alone.

About the Clinical Trial

Clinical trial participants: 945 previously untreated, unresectable, or metastatic melanoma patients

The trial included both BRAF negative (normal BRAF gene) and BRAF positive (abnormal BRAF gene) patients.

Clinical Trial Results

Progression-free survival was 2X greater with OPDIVO alone than with ipilimumab, another immunotherapy, alone

Half of the patients on OPDIVO alone went

6.9 months

without their cancer spreading, growing, or getting worse

COMPARED WITH

2.9 months

with ipilimumab alone

Results were seen in both BRAF negative and BRAF positive patient types.


STUDY 2: PROVEN RESULTS AGAINST CHEMOTHERAPY

About the Clinical Trial

Proven results vs Chemotherapy

Clinical Trial Results

OPDIVO was show to reduce the risk of dying by
58% compared to chemotherapy (dacarbazine)

More than half the OPDIVO patients were alive

at 15 months

 

While half of the chemotherapy patients were alive at

10.8 months

In the same study:

  • Patients treated with OPDIVO had a 57% reduced risk of cancer spreading, growing or getting worse compared to patients who received chemotherapy (dacarbazine)
  • Half the patients treated with OPDIVO went 5.1 months without their cancer spreading, growing or getting worse, compared with 2.2 months for those treated with chemotherapy (dacarbazine)

STUDY 3: PROVEN RESULTS FOR PREVIOUSLY TREATED PATIENTS

About the Clinical Trial

In a separate clinical trial:

120

patients with unresectable or metastatic melanoma whose tumors had progressed after treatment with ipilimumab and, if BRAF positive, a BRAF inhibitor. Responses were seen in both BRAF negative and BRAF positive patients.

all were given OPDIVO

Clinical Trial Results

Patients receiving OPDIVO had an

objective response rate of 32% (38/120),

meaning that they had some response to treatment

  • 3% (4/120) saw their tumors disappear completely (complete response)
  • 28% (34/120) saw their tumors shrink (partial response)

OPDIVO will not work for every patient. Individual results may vary.


Select Important Facts

What are the serious side effects of OPDIVO?

OPDIVO can cause problems that can sometimes become serious or life threatening and can lead to death. Serious side effects may include lung problems (pneumonitis); intestinal problems (colitis) that can lead to tears or holes in your intestine; liver problems (hepatitis); hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas); kidney problems, including nephritis and kidney failure; skin problems; inflammation of the brain (encephalitis); problems in other organs; and severe infusion reactions.

What are the most common side effects of OPDIVO?

The most common side effects of OPDIVO when used alone include:

  • feeling tired
  • pain in muscles, bones, and joints
  • diarrhea
  • weakness
  • shortness of breath
  • decreased appetite
  • upper respiratory tract infection
  • headache
  • rash
  • itchy skin
  • nausea
  • cough
  • constipation
  • back pain
  • fever
  • stomach pain

Talking With Your Doctor Is Key

Review a list of questions with your oncologist about whether OPDIVO is right
for you.

Talk to Your Doctor

Complimentary support, tools, and educational resources for anyone considering or currently taking OPDIVO. Call 1-855-OPDIVO-1 or click the button to learn more.

Sign Up Now

SELECT IMPORTANT FACTS ABOUT OPDIVO

OPDIVO can cause problems that can sometimes become serious or life-threatening and can lead to death. Serious side effects may include lung problems (pneumonitis); intestinal problems (colitis) that can lead to tears or holes in your intestine; liver problems (hepatitis); hormone gland problems (especially the thyroid, pituitary, adrenal glands and pancreas); kidney problems, including nephritis and kidney failure; skin problems; inflammation of the brain (encephalitis); problems in other organs; and severe infusion reactions.

Important Facts about OPDIVO® (nivolumab)

This is a summary of important information that you need to know about OPDIVO. Your healthcare team can work with you to help answer any questions you may have about OPDIVO. Keep this information in a safe place so you can refer to it before and during your treatment.

Look out for the following icons as you read:

  • Talk to your
    healthcare team
  • Call a healthcare
    provider right away
  • Helpful information
    to remember

What is OPDIVO?

OPDIVO is a prescription medicine used to treat people who have a type of skin cancer called melanoma, and who:

Have melanoma that has spread or cannot be removed by surgery (advanced melanoma).

OPDIVO is approved for both BRAF+ and BRAF- patients. OPDIVO was approved for BRAF+ metastatic melanoma patients based on the amount of time patients lived without their tumors worsening. There is ongoing evaluation of clinical benefit of OPDIVO for this use.

It is not known if OPDIVO is safe and effective in children less than 18 years of age.

OPDIVO is a medicine that may treat certain cancers by working with your immune system. It can cause your immune system to attack normal organs and tissues in any area of your body and can affect the way these organs work.


What are the serious side effects of OPDIVO?

A serious side effect is a side effect that can sometimes become life-threatening and can lead to death. They may happen anytime during treatment or even after your treatment has ended.

Get medical help immediately if you develop any of these symptoms or they get worse. It may keep these problems from becoming more serious. Your healthcare team will check you for side effects during treatment with OPDIVO, and may treat you with corticosteroid or hormone replacement medicines. If you have a serious side effect, your healthcare team may need to delay or completely stop your treatment.

Lung problems (pneumonitis) ‐ Things to look out for may include:

  • new or worsening cough
  • chest pain
  • shortness of breath

Intestinal problems (colitis) that can lead to tears or holes in your intestine ‐ Things to look out for may include:

  • diarrhea (loose stools) or more
    bowel movements than usual
  • blood in your stools or dark,
    tarry, sticky stools
  • severe stomach area (abdomen)
    pain or tenderness

Liver problems (hepatitis) ‐ Things to look out for may include:

  • yellowing of your skin or
    the whites of your eyes
  • severe nausea or vomiting
  • pain on the right side of your
    stomach area (abdomen)
  • drowsiness
  • dark urine (tea colored)
  • bleeding or bruising more easily
    than normal
  • feeling less hungry than usual
  • decreased energy

Hormone gland problems (especially the thyroid, pituitary, adrenal glands, and pancreas) ‐ Things to look out for may include:

  • headaches that will not go away
    or unusual headaches
  • extreme tiredness
  • weight gain or weight loss
  • changes in mood or behavior,
    such as decreased sex drive,
    irritability, or forgetfulness
  • hair loss
  • feeling cold
  • constipation
  • voice gets deeper
  • excessive thirst or lots of urine

Kidney problems, including nephritis and kidney failure ‐ Things to look out for may include:

  • decrease in the amount of urine
  • blood in your urine
  • swelling in your ankles
  • loss of appetite

Skin problems ‐ Things to look out for may include:

  • rash
  • itching
  • skin blistering
  • ulcers in the mouth or other
    mucous membranes

Inflammation of the brain (encephalitis) ‐ Things to look out for may include:

  • headache
  • fever
  • tiredness or weakness
  • confusion
  • memory problems
  • sleepiness
  • seeing or hearing things that are not really there (hallucinations)
  • seizures
  • stiff neck

Problems in other organs ‐ Things to look out for may include:

  • changes in eyesight
  • severe or persistent
    muscle or joint pains
  • severe muscle weakness
  • chest pain

Severe infusion reactions ‐ Things to look out for may include:

  • chills or shaking
  • itching or rash
  • flushing
  • difficulty breathing
  • dizziness
  • fever
  • feeling like passing out

Talk to your healthcare team right away if you get any of the symptoms of a severe infusion reaction during or after an infusion of OPDIVO.


What should I discuss with my healthcare team about pregnancy and nursing before starting OPDIVO?

Tell your healthcare team if you are pregnant or plan to become pregnant. OPDIVO can harm your unborn baby. Females who are able to become pregnant should use an effective method of birth control during and for at least 5 months after the last dose of OPDIVO.

Talk to your healthcare team about birth control methods that you can use during this time. Tell your healthcare team right away if you become pregnant during treatment.

Tell your healthcare team if you are breastfeeding or plan to breastfeed. It is not known if OPDIVO passes into your breast milk. Do not breastfeed during treatment.


What should I discuss with my healthcare team before starting OPDIVO?

Talk to your healthcare team about all of your health problems or concerns, including if you:

  • have immune system
    problems such as Crohn’s disease, ulcerative colitis, or lupus
  • have had an organ transplant
  • have lung or breathing problems
  • have liver problems
  • have any other medical conditons

Talk to your healthcare team about all of the medicines you are taking, including:

  • prescription medicines
  • over-the-counter medicines
  • vitamins
  • herbal supplements

What are the most common side effects of OPDIVO?

The most common side effects of OPDIVO when used alone include:

  • feeling tired
  • pain in muscles, bones, and joints
  • diarrhea
  • weakness
  • shortness of breath
  • decreased appetite
  • upper respiratory tract infection
  • headache
  • rash
  • itchy skin
  • nausea
  • cough
  • constipation
  • back pain
  • fever
  • stomach pain

These are not all of the possible side effects of OPDIVO. Talk to your healthcare team for more information.
Call your doctor for medical advice about side effects. You are encouraged to report negative side effects of prescription drugs to the FDA. Visit www.fda.gov/medwatch or call 1-800-FDA-10881-800-FDA-1088. You may also report side effects to Bristol-Myers Squibb
at 1-800-721-5072.


For more information, please see U.S. Full Prescribing Information and Medication Guide for OPDIVO, or talk to your healthcare team.